It’s been a very productive week for cancer research. There’s been a new protein discovered which almost tricked everyone into thinking it was helpful against cancer, and scientists found that just by cancelling some genes tumour growth can occur. Seeing as interesting these discoveries are, let’s delve into them.
First and foremost, let’s talk about the p35 gene. This section of the DNA produces a protein, called p35 protein (who knows why), that can detect abnormal cells, and then start to kill them to prevent them from reproducing, therefore preventing a tumour from forming. This has been known for more than 30 years, and by now we thought we knew all there was to know about it. But the discovery of a variant of this gene hit the news this week. Said gene is called the p35-psi gene, which produces another protein, chemically similar to the p35 protein, which also caused an inflammatory reaction in mutated cells, just like p35 does. But after further study, scientists discovered it does the complete opposite of its cousin: it encourages the growth of cancerous cells. The mechanism works by p35-psi teaming up with another protein, cyclophilin D, which together change the mitochondria organelle so the whole cell itself transforms into a new type, similar-looking to a muscle cell, which usually precedes a cancer.
This opens up a door of possibilities for cancer treatments. New drugs could target cyclophilin D, to stop the transforming process from occurring. Or they could suppress the p35-psi gene to stop it from producing the harmful protein in the first place
Now moving on to the second piece of news.
We all know how mutations can lead to cancers, but the novelty here was that inactivating genes also caused the disease. This can be done through a process called epigenetic methylation, because a methyl group is added to a gene and so prevents it from being transcribed.
Epigenetic methylation occurs naturally in our cells, and actually helps them repair their DNA. But when this process occurs over and over by continuously exposing the same genes to methyl groups, they might just end up permanently attached, effectively cancelling the gene.
The problem, however, is that it is not known for certain whether epigenetic methylation is a cause of cancer or if cancer causes this methylation. In the study carried out, scientists added a new gene into mice cells, a gene that specifically attracted methyl groups and caused methylation in nearby genes. And speaking of tumour suppressing genes, the team in this investigation concentrated on the effects of methylating gene p16, which also prevents the growth of tumours. Over the course of the experiment, those mice with the injected gene had an increased chance of developing cancer, especially in areas like the spleen or the liver.
Although this information does seem to indicate methylation causes cancer, some researchers argue that maybe when they added the new methylating-prone gene, they messed with the already existing genome so it mutated and turned the cell cancerous.
However, since methylation definitely has an effect on cancer, the group of researchers at Baylor College of Medicine in Texas, where the experiment was carried out, will now focus on investigating a way of reversing this process in cancer cells.
It is interesting to note that methylation occurrence can be linked to our diet, since methyl groups come from the food we consume. Some products like green tea and broccoli help decrease methylation rate, so it might be time you had a sip of some delicious tea just in case.